Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2016 August;151(4) > Giornale Italiano di Dermatologia e Venereologia 2016 August;151(4):340-6





A Journal on Dermatology and Sexually Transmitted Diseases

Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,014




Giornale Italiano di Dermatologia e Venereologia 2016 August;151(4):340-6


language: English

The transitioning from conventional therapy to biological treatment in psoriatic patients: STRATOS, a project of Marche Region

Giulia GANZETTI 1, Anna CAMPANATI 1, Maria L. BERNARDINI 1, Alberta BETTACCHI 2, Giuliano BRANDOZZI 1, Valerio BRISIGOTTI 1, Ivana CATALDI 1, Giorgio FILOSA 3, Alfredo GIACCHETTI 4, Giuseppe LEMME 1, Lorenzo MORRESI 5, Massimiliano NICOLINI 3, Valentina POSTACCHINI 1, Giuseppe RICOTTI 4, Laura ROSA 1, Marco SIMONACCI 2, Annamaria OFFIDANI 1

1 Department of Clinical and Molecular Sciences, Dermatological Clinic, Marche Polytechnic University, Ancona, Italy; 2 Unit of Dermatology, Macerata Hospital, ASUR Marche AV3, Macerata, Italy; 3 Unit of Dermatology, “Carlo Urbani” Hospital, ASUR Marche AV2, Jesi, Ancona, Italy; 4 Unit of Dermatology, INRCA/IRCCS, Ancona, Italy; 5 Unit of Dermatology, INRCA/IRCCS, Fermo, Italy


BACKGROUND: STRATOS is the acronym of the “STRuctured Approach to the Treatment of psOriatic patientS”. The optimization of the psoriasis’s therapeutic management is one of the most important goals for dermatologists. According to Mrowietz’s consensus report, the transitioning from conventional therapy to biological therapy is mainly due to the lack/loss of efficacy and/or for safety reasons. The aim of the manuscript was to describe the principal results obtained by the Dermatologic Clinic of Polytechnic University of Marche Region and the Units of Dermatology of the Marche Region applying, in our regional reality, Mrowietz’s protocol for the daily management of patients with moderate-to-severe plaque.
METHODS: Forty-seven patients with moderate to severe chronic plaque psoriasis have been monitored during the six-months study period.
RESULTS: Psoriatic patients with diabetes showed further concomitant comorbidities compared to non-diabetics, as hypertension and hypercholesterolemia. Moreover, based on WHO classification, overweight was diagnosed in female patients, whereas obesity was prevalent in male patients. This aspect confirms the strict link between the multifaceted aspects of psoriatic patient which is primarily related to the persistent low-grade inflammation. In our psoriatic group, 10% of monitored patients were affected by Crohn disease or ulcerative colitis.
CONCLUSIONS: The Mrowietz’s transitioning protocol is a useful, reliable and feasible tool to manage the therapeutic iter of psoriatic patients in an Italian clinical setting also at regional level.

top of page

Publication History

Cite this article as

Corresponding author e-mail